These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37506088)

  • 1. Channeling and dampening: The role of political ties in information disclosure and concealment.
    Zheng W; Ni N; Crilly D
    PLoS One; 2023; 18(7):e0289016. PubMed ID: 37506088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond transparency: Unpacking the financial effects of third-party environmental disclosure in China's semiconductor sector.
    Dagestani AA; Alnafrah I; Ding CJ; Qing L
    J Environ Manage; 2024 Jun; 360():121237. PubMed ID: 38796871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The size, characteristics and partnership networks of the health-related non-profit sector in three regions of South Africa: implications of changing primary health care policy for community-based care.
    van Pletzen E; Zulliger R; Moshabela M; Schneider H
    Health Policy Plan; 2014 Sep; 29(6):742-52. PubMed ID: 23955608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The global diabetes epidemic and the nonprofit state corporate complex: Equity implications of discourses, research agendas, and policy recommendations of diabetes nonprofit organizations.
    Chaufan C; Saliba D
    Soc Sci Med; 2019 Feb; 223():77-88. PubMed ID: 30711782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are partnerships in nonprofit organizations being governed for sustainability? A partnering life cycle assessment.
    Kassem HS; Bagadeem S; Alotaibi BA; Aljuaid M
    PLoS One; 2021; 16(3):e0249228. PubMed ID: 33780510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does environmental responsibility matter in cross-sector partnership formation? A legitimacy perspective.
    Chen J; Zhang F; Liu L; Zhu L
    J Environ Manage; 2019 Feb; 231():612-621. PubMed ID: 30390446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "When doing good is just the start to being good": a possible tool to improve the organizational effectiveness of non-profit health care organizations.
    Mueller J
    J Hosp Mark Public Relations; 2007; 17(2):45-60. PubMed ID: 18072704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Managerial Ties Help or Hinder Corporate Green Innovation? The Moderating Roles of Contextual Factors.
    Zhang Y; Wang Y
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of health sector non-governmental organizations: policy options.
    Gilson L; Sen PD; Mohammed S; Mujinja P
    Health Policy Plan; 1994 Mar; 9(1):14-24. PubMed ID: 10133097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus-related policy-making in Iran: a stakeholder and social network analysis.
    Behzadifar M; Gorji HA; Rezapour A; Rezvanian A; Bragazzi NL; Vatankhah S
    Health Res Policy Syst; 2019 Apr; 17(1):42. PubMed ID: 30992014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.
    Grundy Q; Parker L; Wong A; Fusire T; Dimancesco D; Tisocki K; Walkowiak H; Vian T; Kohler J
    Global Health; 2022 Mar; 18(1):33. PubMed ID: 35303902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing role of health-oriented international organizations and nongovernmental organizations.
    Okma KG; Kay A; Hockenberry S; Liu J; Watkins S
    Int J Health Plann Manage; 2016 Oct; 31(4):488-510. PubMed ID: 26238264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Funds allocation in NPOs: the role of administrative cost ratios.
    Burkart C; Wakolbinger T; Toyasaki F
    Cent Eur J Oper Res; 2018; 26(2):307-330. PubMed ID: 29773965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional effects on nurses' working conditions: a multi-group comparison of public and private non-profit and for-profit healthcare employers in Switzerland.
    Aeschbacher R; Addor V
    Hum Resour Health; 2018 Nov; 16(1):58. PubMed ID: 30413167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Nonprofit-Private Collaboration for Nonprofits' Organizational Resilience.
    Waerder R; Thimmel S; Englert B; Helmig B
    Voluntas; 2022; 33(4):672-684. PubMed ID: 34720457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The for-profit sector in humanitarian response: integrating ethical considerations in public policy decision making.
    Huckel Schneider C; Negin J
    Med Confl Surviv; 2016; 32(3):184-202. PubMed ID: 27825277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the complex relationships among actors involved in the implementation of public-private mix (PPM) for TB control in India, using social theory.
    Salve S; Harris K; Sheikh K; Porter JDH
    Int J Equity Health; 2018 Jun; 17(1):73. PubMed ID: 29880052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-profit sector and the market: opportunities & challenges.
    Fund Raising Manage; 2001 Nov; 32(9):42, 46-8. PubMed ID: 11881451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.